drugset / Trial / NCT02361216

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

NCT02361216

Phase 3 Completed 729 enrolled LEO Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of the trial is to investigate efficacy and safety of ingenol mebutate gel for actinic keratosis applied to large treatment areas once daily for three consecutive days on face, scalp or chest.

Timeline

Start
2015-04
Primary completion
2016-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ingenol mebutate Small molecule Topical

Indications